OncoMatch/Clinical Trials/Hodgkin Lymphoma (HL)
Hodgkin Lymphoma (HL) Clinical Trials
OncoMatch filters Hodgkin Lymphoma (HL) trials by the molecular markers that determine eligibility — CD274, CD30, CD20, CD19, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Hodgkin Lymphoma (HL) trials
These are the molecular markers most commonly required or evaluated in Hodgkin Lymphoma (HL) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Hodgkin Lymphoma (HL) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
University College, London
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
Hospital Regional de Alta Especialidad del Bajio
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
University of Birmingham
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
Shanghai Junshi Bioscience Co., Ltd.
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Rita Assi
How OncoMatch finds Hodgkin Lymphoma (HL) trials for you
AI reads the protocol
Every Hodgkin Lymphoma (HL) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Hodgkin Lymphoma (HL) and mark your biomarker results — CD274, CD30, CD20 — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.